1123 related articles for article (PubMed ID: 24071464)
41. Epinephrine-mediated protein kinase C and Rap1b activation requires the co-stimulation of Gz-, Gq-, and Gi-coupled receptors.
Lova P; Guidetti GF; Canobbio I; Catricalà S; Balduini C; Torti M
Thromb Haemost; 2011 Mar; 105(3):479-86. PubMed ID: 21136013
[TBL] [Abstract][Full Text] [Related]
42. Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling.
Schweigel H; Geiger J; Beck F; Buhs S; Gerull H; Walter U; Sickmann A; Nollau P
Proteomics; 2013 Mar; 13(6):1016-27. PubMed ID: 23322602
[TBL] [Abstract][Full Text] [Related]
43. Modified diadenosine tetraphosphates with dual specificity for P2Y1 and P2Y12 are potent antagonists of ADP-induced platelet activation.
Chang H; Yanachkov IB; Dix EJ; Li YF; Barnard MR; Wright GE; Michelson AD; Frelinger AL
J Thromb Haemost; 2012 Dec; 10(12):2573-80. PubMed ID: 23083103
[TBL] [Abstract][Full Text] [Related]
44. Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor.
Moore DJ; Chambers JK; Murdock PR; Emson PC
Neuropharmacology; 2002 Nov; 43(6):966-78. PubMed ID: 12423666
[TBL] [Abstract][Full Text] [Related]
45. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
46. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
Scavone M; Germanovich K; Femia EA; Cattaneo M
Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
[TBL] [Abstract][Full Text] [Related]
47. A molecularly identified P2Y receptor simultaneously activates phospholipase C and inhibits adenylyl cyclase and is nonselectively activated by all nucleoside triphosphates.
Boyer JL; Delaney SM; Villanueva D; Harden TK
Mol Pharmacol; 2000 Apr; 57(4):805-10. PubMed ID: 10727529
[TBL] [Abstract][Full Text] [Related]
48. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice.
Fabre JE; Nguyen M; Latour A; Keifer JA; Audoly LP; Coffman TM; Koller BH
Nat Med; 1999 Oct; 5(10):1199-202. PubMed ID: 10502826
[TBL] [Abstract][Full Text] [Related]
49. Low structural specificity for nucleoside triphosphates as antagonists of ADP-induced platelet activation.
Greco NJ; Tandon NN; Jackson BW; Jamieson GA
J Biol Chem; 1992 Feb; 267(5):2966-70. PubMed ID: 1737752
[TBL] [Abstract][Full Text] [Related]
50. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase.
Albert JL; Boyle JP; Roberts JA; Challiss RA; Gubby SE; Boarder MR
Br J Pharmacol; 1997 Nov; 122(5):935-41. PubMed ID: 9384512
[TBL] [Abstract][Full Text] [Related]
51. The P2Y1 receptor plays an essential role in the platelet shape change induced by collagen when TxA2 formation is prevented.
Mangin P; Ohlmann P; Eckly A; Cazenave JP; Lanza F; Gachet C
J Thromb Haemost; 2004 Jun; 2(6):969-77. PubMed ID: 15140133
[TBL] [Abstract][Full Text] [Related]
52. New highly active antiplatelet agents with dual specificity for platelet P2Y1 and P2Y12 adenosine diphosphate receptors.
Yanachkov IB; Chang H; Yanachkova MI; Dix EJ; Berny-Lang MA; Gremmel T; Michelson AD; Wright GE; Frelinger AL
Eur J Med Chem; 2016 Jan; 107():204-18. PubMed ID: 26588064
[TBL] [Abstract][Full Text] [Related]
53. Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.
Gremmel T; Yanachkov IB; Yanachkova MI; Wright GE; Wider J; Undyala VV; Michelson AD; Frelinger AL; Przyklenk K
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):501-9. PubMed ID: 26743169
[TBL] [Abstract][Full Text] [Related]
54. The role of ADP receptors in platelet function.
Murugappa S; Kunapuli SP
Front Biosci; 2006 May; 11():1977-86. PubMed ID: 16368572
[TBL] [Abstract][Full Text] [Related]
55. Diverse signalling of the platelet P2Y
Amison RT; Jamshidi S; Rahman KM; Page CP; Pitchford SC
Eur J Pharmacol; 2018 May; 827():58-70. PubMed ID: 29534999
[TBL] [Abstract][Full Text] [Related]
56. Antipsychotic Drugs Inhibit Platelet Aggregation via P2Y 1 and P2Y 12 Receptors.
Wu CC; Tsai FM; Chen ML; Wu S; Lee MC; Tsai TC; Wang LK; Wang CH
Biomed Res Int; 2016; 2016():2532371. PubMed ID: 27069920
[TBL] [Abstract][Full Text] [Related]
57. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
[TBL] [Abstract][Full Text] [Related]
58. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
Soslau G; McKenzie RJ; Brodsky I; Devlin TM
Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
[TBL] [Abstract][Full Text] [Related]
59. Pharmacology and structure of P2Y receptors.
von Kügelgen I; Hoffmann K
Neuropharmacology; 2016 May; 104():50-61. PubMed ID: 26519900
[TBL] [Abstract][Full Text] [Related]
60. In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation.
Armstrong PC; Leadbeater PD; Chan MV; Kirkby NS; Jakubowski JA; Mitchell JA; Warner TD
J Thromb Haemost; 2011 Mar; 9(3):552-61. PubMed ID: 21143373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
